Facebook-f X-twitter Linkedin-in Instagram Podcast

Podcasts

Episode 3 | 2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer

Prof Nick Pavlakis and Prof Emily Stone join discuss the remarkable advances in screening, diagnosing and treating lung cancer that occurred during 2020.

2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer

Episode Summary

Prof Nick Pavlakis and Prof Emily Stone discuss the remarkable advances in screening, diagnosing, and treating lung cancer. This episode delves into the public health measures to ensure the survival increase we are seeing for patients with lung cancer continues to accelerate into this decade.

 

Sponsored with a Takeda Educational Grant.

Show Hosts

This episode’s host are:

  • Prof Nick Pavlakis, Chair, TOGA; Senior Staff Specialist, Department of Medical Oncology, Royal North Shore Hospital
  • Prof Emily Stone, Deputy Chair, TOGA; Respiratory Physician, Senior Staff Specialist and Head of Thoracic Medicine, Department of Thoracic Medicine and Lung Transplantation, St Vincent’s Hospital Sydney; conjoint Senior Lecturer, University of New South Wales; Chair, St Vincent’s Hospital Lung Cancer Multidisciplinary team

Play Episode 3 | 2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer

Download Audio File
Listen on Apple
Listen on Spotify

More Podcasts

Prof Tom John Prof Georgina Long AO Prof Ken O'Byrne
51 – Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy
In this episode, Prof Tom John, Prof Georgina Long AO, and Prof Ken O'Byrne delve into technological advances spurred by COVID-19 vaccine development, promising results
50 – The Role of Liquid Biopsy in Modern Oncology
In this episode, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Steven Kao discuss the concept of liquid biopsy, its advantages and limitations, and its
Headshots of A/Prof Surein Arulananda, A/Prof Mel Moore, Dr. Malinda Itchins. 49 Exploring EGFR Exon 20 Insertion Mutations
49 – Exploring EGFR Exon 20 Insertion Mutations
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda, delve into
Conversations in Lung Cancer Research - Michael Boyer
48 – A Conversation with Prof. Michael Boyer
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and
Text Conversations in Lung Cancer on Blue background and TOGA logo
47 – Introducing Conversations in Lung Cancer Research
In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'
46 – Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy
Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC
Join our community – stay up to date with the latest research, TOGA news and events

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Contact

PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198

Facebook-f X-twitter Linkedin-in Instagram Podcast
TOGA
Quicklinks
TOGA is an ACNC Registered Charity

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.

Copyright © 2025 TOGA – Thoracic Oncology Group Australasia. No part of this site may be reproduced without our written permission.